1931P Phase II Study of PDR001 in Combination with MAPK Pathway Inhibitors in Patients with Radioactive-Refractory Differentiated Thyroid Cancer (DTC) W. Wong,E.J. Sherman, A. Kriplani, L. Michel, I. Zhi, T.K.W. Hung, L. Dunn,R.K. Grewal, G. Krishnamoorthy,I. Ostrovnaya,N. Katabi,J. Fagin, D. Pfister,A.L. HoAnnals of Oncology（2024）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
